Anticancer agent and side-effect-alleviating agent
The purpose of the present invention is to provide an anticancer agent for potentiating an antitumor effect, alleviating side effects, and further extending the survival rate by concomitant use with a component having an anticancer effect. An anticancer agent combining arctigenin and a component other than arctigenin that has an anticancer effect, in which the anticancer agent may be a combination drug or may be a kit configured from a formulation containing arctigenin and a formulation containing a component that has an anticancer effect, and the concomitant use of arctigenin and the component having an anticancer effect more strongly inhibits tumor growth and reduces the proportion of cancer stem cells in the tumor, making it possible to extend the total survival time and to alleviate side effects caused by the component having an anticancer effect.
1. A method for normalizing intra-tumor blood vessels in a subject in need thereof, the method comprising administering an effective dose of arctigenin to the subject, whereby intra tumor blood vessels are normalized.
2. A method for enhancing drug delivery of a component having an anticancer activity to a tumor tissue in a subject in need thereof, the method comprising administering an effective dose of arctigenin to the subject, whereby drug delivery to said tumor tissue is enhanced.
3. A method for alleviating a lowering of the weight/body weight rate (%) of liver and spleen or hepatopathy caused by a component having an anticancer activity other than arctigenin in a subject in need of thereof, comprising administering an effective dose of arctigenin to the subject, whereby said weight/body weight rate (%) of liver and/or spleen or hepatopathy is lowered.
4. The method of claim 1 , wherein the arctigenin is a Burdock fruit extract.
5. The method of claim 2 , wherein the arctigenin is a Burdock fruit extract.
6. The method of claim 3 , wherein the arctigenin is a Burdock fruit extract.